CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter...
Q1 2026
May 14, 2026
FY 2025
Mar 5, 2026
Q4 2025
Q3 2025
Nov 12, 2025
Q2 2025
Aug 7, 2025
